FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562133150> ?p ?o ?g. }

• W2562133150 abstract "Abstract Background: An increased risk of morbidity, including second primary malignancies and cardiovascular disease, has been reported in survivors of Hodgkin lymphoma (HL) diagnosed during adulthood. However, in contrast to our understanding of the late effects of treatment of children with HL, the global burden of chronic morbidity among long-term survivors of adult-onset HL is poorly characterized. Methods: We conducted a survey-based cohort study of patients treated as adults with protocol-based first-line therapy for HL at our center from 1975 to 2000. The protocols included 6 combined modality trials (CMT) of chemotherapy (CT) + radiation therapy (RT), with the exception of a single CT-only arm in 1 trial. Chronic health conditions were assigned severity scores based on a modification of the Common Terminology Criteria for Adverse Events, version 3 (grades 1 through 4, ranging from mild to life-threatening or disabling). Results: Of 707 patients for whom follow-up was available, 517 were alive. Median survival was 29 years. Survey data were available from 169 patients, with a median time from last treatment to interview date of 21 years. Of responders, median age at interview was 48 years (range, 25–88) and median age at treatment was 29 years (range, 16–66). Fifty percent were women, and 96% were white, non-Hispanic. Self-reported chronic health conditions were very common in our cohort: 94% of respondents reported any chronic health condition, and 60% described chronic health conditions that were grades 3 or 4 in severity (Table 1). Frequently reported conditions included cardiovascular, musculoskeletal, endocrine, and psychiatric disorders. Sixty percent of patients reported grade ≥1 cardiovascular dysfunction (20% ≥grade 3), 40% grade ≥1 musculoskeletal (7% ≥grade 3), 71% ≥grade 1 endocrine (17% ≥grade 3), and 23% ≥grade 1 psychiatric (21% ≥grade 3). Second primary malignancies were reported by 23%, and infectious conditions by 34%. Additional data collection on surviving and deceased patients is ongoing. Conclusions: These results document the high prevalence of chronic illness among survivors of HL treated as adults. Evidence-based guidelines built upon such data are needed to aid clinicians in the management of the late morbidities associated with HL treatment. Table 1. Chronic health conditions among adult-onset Hodgkin lymphoma survivors, according to severity score. Health Condition Frequency (%) Conditions by grade No condition 10 (6%) Grade 1 17 (10%) Grade 2 41 (24%) Grade 3 67 (40%) Grade 4 34 (20%) Any condition Grades 1–4 159 (94%) Grade 3 or 4 101 (60%) Multiple health conditions ≥Grade 1 ≥2 conditions 142 (84%) ≥3 conditions 120 (71%) ≥Grade 2 ≥2 conditions 111 (66%) ≥3 conditions 72 (43%) ≥Grade 3 ≥2 conditions 50 (30%) ≥3 conditions 19 (11%)" @default.
• W2562133150 created "2017-01-06" @default.
• W2562133150 creator A5003777656 @default.
• W2562133150 creator A5006117950 @default.
• W2562133150 creator A5022487235 @default.
• W2562133150 creator A5026688095 @default.
• W2562133150 creator A5049461398 @default.
• W2562133150 creator A5064079432 @default.
• W2562133150 creator A5078465445 @default.
• W2562133150 date "2007-11-16" @default.
• W2562133150 modified "2023-09-26" @default.
• W2562133150 title "High Prevalence of Chronic Health Conditions in Survivors of Hodgkin Lymphoma Treated during Adulthood." @default.
• W2562133150 doi "https://doi.org/10.1182/blood.v110.11.4390.4390" @default.
• W2562133150 hasPublicationYear "2007" @default.
• W2562133150 type Work @default.
• W2562133150 sameAs 2562133150 @default.
• W2562133150 citedByCount "0" @default.
• W2562133150 crossrefType "journal-article" @default.
• W2562133150 hasAuthorship W2562133150A5003777656 @default.
• W2562133150 hasAuthorship W2562133150A5006117950 @default.
• W2562133150 hasAuthorship W2562133150A5022487235 @default.
• W2562133150 hasAuthorship W2562133150A5026688095 @default.
• W2562133150 hasAuthorship W2562133150A5049461398 @default.
• W2562133150 hasAuthorship W2562133150A5064079432 @default.
• W2562133150 hasAuthorship W2562133150A5078465445 @default.
• W2562133150 hasConcept C126322002 @default.
• W2562133150 hasConcept C187212893 @default.
• W2562133150 hasConcept C2777793932 @default.
• W2562133150 hasConcept C509974204 @default.
• W2562133150 hasConcept C71924100 @default.
• W2562133150 hasConcept C72563966 @default.
• W2562133150 hasConceptScore W2562133150C126322002 @default.
• W2562133150 hasConceptScore W2562133150C187212893 @default.
• W2562133150 hasConceptScore W2562133150C2777793932 @default.
• W2562133150 hasConceptScore W2562133150C509974204 @default.
• W2562133150 hasConceptScore W2562133150C71924100 @default.
• W2562133150 hasConceptScore W2562133150C72563966 @default.
• W2562133150 hasLocation W25621331501 @default.
• W2562133150 hasOpenAccess W2562133150 @default.
• W2562133150 hasPrimaryLocation W25621331501 @default.
• W2562133150 hasRelatedWork W2010598925 @default.
• W2562133150 hasRelatedWork W2023114078 @default.
• W2562133150 hasRelatedWork W2061163194 @default.
• W2562133150 hasRelatedWork W2070338448 @default.
• W2562133150 hasRelatedWork W2071535500 @default.
• W2562133150 hasRelatedWork W2316407790 @default.
• W2562133150 hasRelatedWork W2603773853 @default.
• W2562133150 hasRelatedWork W2739441279 @default.
• W2562133150 hasRelatedWork W2889952062 @default.
• W2562133150 hasRelatedWork W2982164358 @default.
• W2562133150 isParatext "false" @default.
• W2562133150 isRetracted "false" @default.
• W2562133150 magId "2562133150" @default.
• W2562133150 workType "article" @default.